Cleveland BioLabs (Cleveland BioLabs) Quick Ratio : 28.37 (As of Mar. 2021)

View and export this data going back to 2006. Start your Free Trial

What is Cleveland BioLabs Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Cleveland BioLabs's quick ratio for the quarter that ended in Mar. 2021 was 28.37.

Cleveland BioLabs has a quick ratio of 28.37. It generally indicates good short-term financial strength.

The historical rank and industry rank for Cleveland BioLabs's Quick Ratio or its related term are showing as below:

CBLI' s Quick Ratio Range Over the Past 10 Years
Min: 0.3 Med: 3.14 Max: 28.37
Current: 28.37

During the past 13 years, Cleveland BioLabs's highest Quick Ratio was 28.37. The lowest was 0.30. And the median was 3.14.

CBLI's Quick Ratio is not ranked
in the Biotechnology industry.
Industry Median: 3.485 vs CBLI: 28.37

Cleveland BioLabs Quick Ratio Historical Data

The historical data trend for Cleveland BioLabs's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cleveland BioLabs Quick Ratio Chart

Cleveland BioLabs Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Quick Ratio

Get a 7-Day Free Trial

5.11

4.33

4.91

1.90

7.59

Cleveland BioLabs Quarterly Data
	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21
Quick Ratio	Get a 7-Day Free Trial															1.69	5.17	6.66	7.59	28.37

Competitive Comparison of Cleveland BioLabs's Quick Ratio

For the Biotechnology subindustry, Cleveland BioLabs's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cleveland BioLabs's Quick Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cleveland BioLabs's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Cleveland BioLabs's Quick Ratio falls into.

Cleveland BioLabs Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Cleveland BioLabs's Quick Ratio for the fiscal year that ended in Dec. 2020 is calculated as

Quick Ratio (A: Dec. 2020 )	=	(Total Current Assets	-	Total Inventories)	/	Total Current Liabilities
	=	(2.314	-	0)	/	0.305
	=	7.59

Cleveland BioLabs's Quick Ratio for the quarter that ended in Mar. 2021 is calculated as

Quick Ratio (Q: Mar. 2021 )	=	(Total Current Assets	-	Total Inventories)	/	Total Current Liabilities
	=	(14.694	-	0)	/	0.518
	=	28.37

Cleveland BioLabs (NAS:CBLI) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.

Cleveland BioLabs Quick Ratio Related Terms

Thank you for viewing the detailed overview of Cleveland BioLabs's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Cleveland BioLabs (Cleveland BioLabs) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cleveland BioLabs Inc (NAS:CBLI) » Definitions » Quick Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

73 High Street, Buffalo, NY, USA, 14203

Website

http://www.cbiolabs.com

Cleveland BioLabs Inc is a biopharmaceutical company. The company is developing novel approaches to activate the immune system and address serious medical needs. Its proprietary platform of Toll-like immune receptor activators has applications in the mitigation of radiation injury and immuno-oncology. Its lead product candidate is entolimod, an immuno-stimulatory agent, which is developed as a radiation countermeasure and immunotherapy for oncology and other indications. Entolimod is a Toll-like receptor 5 (TLR5) agonist, which is developed as a radiation countermeasure for the prevention of death from Acute Radiation Syndrome (ARS), and as an oncology drug.

Executives

Christopher Zosh	officer: Vice President of Finance	C/O CLEVELAND BIOLABS, INC., 73 HIGH STREET, BUFFALO NY 14203
Ivan Fedyunin	director	73 HIGH STREET, BUFFALO NY 14203
John Edward Szydlo	officer: Principal Financial Officer	73 HIGH STREET, BUFFALO NY 14203
Randy S. Saluck	director	C/O CLEVELAND BIOLABS, INC., 73 HIGH STREET, BUFFALO NY 14203
Alexander Andryushechkin	director	73 HIGH STREET, BUFFALO NY 14203
Daniil Talyanskiy	director	73 HIGH STREET, BUFFALO NY 14203
Alexey Nechaev	director	73 HIGH STREET, BUFFALO NY 14203
Lea Verny	director	73 HIGH STREET, BUFFALO NY 14203
Tatiana Levina	director	10-12 EMMANOUIL ROIDI STR, LIMASSOL G4 CY3031
Ivan Persiyanov	director	4 SADOVNICHESKAYA ST, MOSCOW 1Z 115035
Anna Evdokimova	director	9-96 UNIVERSITETSKIY PROSPEKT, MOSCOW 1Z 119296
Yulia Lebedina	director	5 MALYSHEVA STREET, FLAT 7, MOSCOW 1Z 109129
Konstantin Gorshkov	director	10-12 EMMANOUIL ROIDI STR, LIMASSOL G4 CY3031
Natalia Saraeva	director	10-12 EMMANOUIL ROIDI STR, LIMASSOL G4 CY3031
Natalia Khudyk	director	10-12 EMMANOUIL ROIDI STR, LIMASSOL G4 CY3031